The abstract is read at the publisher; the summary is JClub's.
FANCM is a selective dependency in PAX3::FOXO1+ alveolar rhabdomyosarcoma, where its loss reduces fusion protein levels and disrupts the oncogenic transcriptional program.
- Why it matters: Oncogenic TF fusions like PAX3::FOXO1 hyperactivate and mislocalize TF functions, creating replication stress that tumors must manage to keep proliferating.
- What they did: Using sequential functional genomic CRISPR-Cas9 screens, the study identified FANCM, then tested how FANCM depletion affects fusion protein abundance, myogenic differentiation, and PAX3::FOXO1 target gene regulation.
- The result: FANCM loss increases replication stress and DNA damage signaling, with chromatin-associated replication stress enriched at PAX3::FOXO1 target loci, leading to selective downregulation of the oncogenic program and halting proliferation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.